Brain uptake of benzodiazepines: Effects of lipophilicity and plasma protein binding

D. R. Jones, S. D. Hall, E. K. Jackson, R. A. Branch, G. R. Wilkinson

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

The rapid intracarotid injection technique was used to determine the unidirectional brain uptake of a number of benzodiazepines in the rat. The drugs varied considerably in their lipophilicity and, within the series oxazepam, lorazepam, chlordiazepoxide, desmethyldiazepam and diazepam, brain extraction of unbound moiety was enhanced as the octanol-water (pH = 7.4) partition coefficient increased. However, with flunitrazepam and midazolam, two fluorine-containing benzodiazepines, extraction was more and less extensive, respectively, than predicted from their lipophilicities. Importantly, the uptake findings were consistent with the characteristic onsets of central effects of the drugs established clinically in humans. The effects of reversible protein binding on uptake also were investigated by the addition of albumin (0-8 g·dl-1) to the injectate. This affected markedly the unbound fraction, determined in vitro by equilibrium dialysis, and also the brain uptake of all drugs. As the unbound fraction was reduced, the unidirectional brain extraction ratio decreased in a curvilinear fashion toward zero. However, attempts to describe the data were unsuccessful using a conventional model based on transcapillary uptake of only unbound drug whose binding kinetics with albumin were assumed to be the same as those indicated by equilibrium dialysis. The observed brain extraction was greater than predicted, and the discrepancy became more apparent as binding and albumin concentration increased. The data for all of the benzodiazepines could be fitted, however, if the equilibrium association constant was assumed to be smaller in vivo than in vitro, so that the effective unbound fraction in the brain capillaries was substantially higher (5- to 25-fold, dependent on the particular drug) than that estimated in vitro. The mechanism of such in vivo enhanced dissociation is as yet unclear, but the results question conventional concepts regarding the tissue uptake of plasma protein bound drugs and suggest that in vitro estimates of binding may not reflect the situation in the blood capillaries, at least under nonequilibrium, nonsteady-state conditions.

Original languageEnglish (US)
Pages (from-to)816-822
Number of pages7
JournalJournal of Pharmacology and Experimental Therapeutics
Volume245
Issue number3
StatePublished - 1988
Externally publishedYes

Fingerprint

Benzodiazepines
Protein Binding
Blood Proteins
Brain
Pharmaceutical Preparations
Albumins
Dialysis
Nordazepam
Oxazepam
Flunitrazepam
Chlordiazepoxide
Lorazepam
Octanols
Fluorine
Midazolam
Diazepam
Injections
In Vitro Techniques
Water

ASJC Scopus subject areas

  • Pharmacology

Cite this

Jones, D. R., Hall, S. D., Jackson, E. K., Branch, R. A., & Wilkinson, G. R. (1988). Brain uptake of benzodiazepines: Effects of lipophilicity and plasma protein binding. Journal of Pharmacology and Experimental Therapeutics, 245(3), 816-822.

Brain uptake of benzodiazepines : Effects of lipophilicity and plasma protein binding. / Jones, D. R.; Hall, S. D.; Jackson, E. K.; Branch, R. A.; Wilkinson, G. R.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 245, No. 3, 1988, p. 816-822.

Research output: Contribution to journalArticle

Jones, DR, Hall, SD, Jackson, EK, Branch, RA & Wilkinson, GR 1988, 'Brain uptake of benzodiazepines: Effects of lipophilicity and plasma protein binding', Journal of Pharmacology and Experimental Therapeutics, vol. 245, no. 3, pp. 816-822.
Jones, D. R. ; Hall, S. D. ; Jackson, E. K. ; Branch, R. A. ; Wilkinson, G. R. / Brain uptake of benzodiazepines : Effects of lipophilicity and plasma protein binding. In: Journal of Pharmacology and Experimental Therapeutics. 1988 ; Vol. 245, No. 3. pp. 816-822.
@article{f7ecd6ec217b48e0a23c9b8f17ba1899,
title = "Brain uptake of benzodiazepines: Effects of lipophilicity and plasma protein binding",
abstract = "The rapid intracarotid injection technique was used to determine the unidirectional brain uptake of a number of benzodiazepines in the rat. The drugs varied considerably in their lipophilicity and, within the series oxazepam, lorazepam, chlordiazepoxide, desmethyldiazepam and diazepam, brain extraction of unbound moiety was enhanced as the octanol-water (pH = 7.4) partition coefficient increased. However, with flunitrazepam and midazolam, two fluorine-containing benzodiazepines, extraction was more and less extensive, respectively, than predicted from their lipophilicities. Importantly, the uptake findings were consistent with the characteristic onsets of central effects of the drugs established clinically in humans. The effects of reversible protein binding on uptake also were investigated by the addition of albumin (0-8 g·dl-1) to the injectate. This affected markedly the unbound fraction, determined in vitro by equilibrium dialysis, and also the brain uptake of all drugs. As the unbound fraction was reduced, the unidirectional brain extraction ratio decreased in a curvilinear fashion toward zero. However, attempts to describe the data were unsuccessful using a conventional model based on transcapillary uptake of only unbound drug whose binding kinetics with albumin were assumed to be the same as those indicated by equilibrium dialysis. The observed brain extraction was greater than predicted, and the discrepancy became more apparent as binding and albumin concentration increased. The data for all of the benzodiazepines could be fitted, however, if the equilibrium association constant was assumed to be smaller in vivo than in vitro, so that the effective unbound fraction in the brain capillaries was substantially higher (5- to 25-fold, dependent on the particular drug) than that estimated in vitro. The mechanism of such in vivo enhanced dissociation is as yet unclear, but the results question conventional concepts regarding the tissue uptake of plasma protein bound drugs and suggest that in vitro estimates of binding may not reflect the situation in the blood capillaries, at least under nonequilibrium, nonsteady-state conditions.",
author = "Jones, {D. R.} and Hall, {S. D.} and Jackson, {E. K.} and Branch, {R. A.} and Wilkinson, {G. R.}",
year = "1988",
language = "English (US)",
volume = "245",
pages = "816--822",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Brain uptake of benzodiazepines

T2 - Effects of lipophilicity and plasma protein binding

AU - Jones, D. R.

AU - Hall, S. D.

AU - Jackson, E. K.

AU - Branch, R. A.

AU - Wilkinson, G. R.

PY - 1988

Y1 - 1988

N2 - The rapid intracarotid injection technique was used to determine the unidirectional brain uptake of a number of benzodiazepines in the rat. The drugs varied considerably in their lipophilicity and, within the series oxazepam, lorazepam, chlordiazepoxide, desmethyldiazepam and diazepam, brain extraction of unbound moiety was enhanced as the octanol-water (pH = 7.4) partition coefficient increased. However, with flunitrazepam and midazolam, two fluorine-containing benzodiazepines, extraction was more and less extensive, respectively, than predicted from their lipophilicities. Importantly, the uptake findings were consistent with the characteristic onsets of central effects of the drugs established clinically in humans. The effects of reversible protein binding on uptake also were investigated by the addition of albumin (0-8 g·dl-1) to the injectate. This affected markedly the unbound fraction, determined in vitro by equilibrium dialysis, and also the brain uptake of all drugs. As the unbound fraction was reduced, the unidirectional brain extraction ratio decreased in a curvilinear fashion toward zero. However, attempts to describe the data were unsuccessful using a conventional model based on transcapillary uptake of only unbound drug whose binding kinetics with albumin were assumed to be the same as those indicated by equilibrium dialysis. The observed brain extraction was greater than predicted, and the discrepancy became more apparent as binding and albumin concentration increased. The data for all of the benzodiazepines could be fitted, however, if the equilibrium association constant was assumed to be smaller in vivo than in vitro, so that the effective unbound fraction in the brain capillaries was substantially higher (5- to 25-fold, dependent on the particular drug) than that estimated in vitro. The mechanism of such in vivo enhanced dissociation is as yet unclear, but the results question conventional concepts regarding the tissue uptake of plasma protein bound drugs and suggest that in vitro estimates of binding may not reflect the situation in the blood capillaries, at least under nonequilibrium, nonsteady-state conditions.

AB - The rapid intracarotid injection technique was used to determine the unidirectional brain uptake of a number of benzodiazepines in the rat. The drugs varied considerably in their lipophilicity and, within the series oxazepam, lorazepam, chlordiazepoxide, desmethyldiazepam and diazepam, brain extraction of unbound moiety was enhanced as the octanol-water (pH = 7.4) partition coefficient increased. However, with flunitrazepam and midazolam, two fluorine-containing benzodiazepines, extraction was more and less extensive, respectively, than predicted from their lipophilicities. Importantly, the uptake findings were consistent with the characteristic onsets of central effects of the drugs established clinically in humans. The effects of reversible protein binding on uptake also were investigated by the addition of albumin (0-8 g·dl-1) to the injectate. This affected markedly the unbound fraction, determined in vitro by equilibrium dialysis, and also the brain uptake of all drugs. As the unbound fraction was reduced, the unidirectional brain extraction ratio decreased in a curvilinear fashion toward zero. However, attempts to describe the data were unsuccessful using a conventional model based on transcapillary uptake of only unbound drug whose binding kinetics with albumin were assumed to be the same as those indicated by equilibrium dialysis. The observed brain extraction was greater than predicted, and the discrepancy became more apparent as binding and albumin concentration increased. The data for all of the benzodiazepines could be fitted, however, if the equilibrium association constant was assumed to be smaller in vivo than in vitro, so that the effective unbound fraction in the brain capillaries was substantially higher (5- to 25-fold, dependent on the particular drug) than that estimated in vitro. The mechanism of such in vivo enhanced dissociation is as yet unclear, but the results question conventional concepts regarding the tissue uptake of plasma protein bound drugs and suggest that in vitro estimates of binding may not reflect the situation in the blood capillaries, at least under nonequilibrium, nonsteady-state conditions.

UR - http://www.scopus.com/inward/record.url?scp=0023944548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023944548&partnerID=8YFLogxK

M3 - Article

C2 - 3385643

AN - SCOPUS:0023944548

VL - 245

SP - 816

EP - 822

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -